Amneal Pharmaceuticals (AMRX) Other Accumulated Expenses (2018 - 2019)

Amneal Pharmaceuticals' Other Accumulated Expenses history runs 2 years deep, the most recent figure standing at $35.9 million for Q4 2019.

• On a quarterly basis, Other Accumulated Expenses fell 0.82% year-over-year to $35.9 million in Q4 2019; TTM through Dec 2019 was $35.9 million, a 0.82% decrease from a year earlier, with the FY2019 full-year figure at $35.9 million, down 0.82% from the prior year.
• Other Accumulated Expenses eased to $35.9 million in Q4 2019 per AMRX's latest filing, from $36.2 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $36.2 million in Q4 2018 and bottomed at $35.9 million in Q4 2019.